
Aiming for the Sun: How the $11.75 billion Organon buy is cementing Dilip Shanghvi’s legacy
Sun Pharmaceutical Industries has struck its largest global deal to acquire US-based Organon for $11.75 billion. This deal expands Sun Pharma’s footprint to 150 markets.




